Nicotinic acetylcholine receptors (nAChRs) display a broad variety of subtypes, which in turn present a complex subcellular and regional expression pattern in the brain, as well as a specific pharmacological profile. The association of these nAChRs with different types of brain disease has turned them into interesting drug targets for the treatment of Alzheimer's disease or schizophrenia, or for anti-smoking compounds among others. In the same way, muscle-type nAChRs present at neuromuscular junctions are also being targeted by muscle relaxants. However, to date no high-resolution structural data is available on functional 
Introduction
Cys-loop receptors (CLRs) are key to neuronal transmission processes both in the central and peripheral nervous systems. CLRs display a similar organization, as homo-or heteropentameric assemblies. Each protomer is composed of an extracellular N-terminal ligand binding domain (LBD) which displays a characteristic 12-13 amino acids long Cys-Cys loop, four C-terminal membrane spanning regions (M1-M4) and an intracellular region extending from M3 to M4 [1] [2] [3] . In vertebrates, the CLR family comprises the cation-selective nicotinic acetylcholine receptors (nAChRs), the 5-HT 3 receptors, as well as the anion-selective glycine and GABA A/C receptors. CLRs constitute interesting drug targets. nAChRs are drug targets in treating cognitive decline in Alzheimer's disease, certain forms of epilepsy or nicotine addiction [4] . Drugs directed towards 5HT 3 receptors are used in case of emesis [5] . GABA A receptors are modulated by anesthetics or by compounds such as benzodiazepines to treat sleep or mood disturbances [6] . Glycine receptors, involved in sensory signal processing, are potential drug targets for relieving peripheral inflammatory pain or spastic conditions [7, 8] . A common aspect of neurotransmitter binding is that it takes place at the subunit interfaces of the extracellular LBD whereas the transmembrane regions form the ion channel and constitute the ion selectivity filters.
nAChRs are prototypical members of the CLR family. They respond to the neurotransmitters acetylcholine and choline and are targeted by many non-endogenous neuroactive compounds like nicotine and snail and snake venom components, such as α-Conotoxins and α-Bungarotoxin, respectively [9] . nAChRs group into muscle-type and neuronal receptors.
Muscle-type receptors are composed of four different subunits assembled with the (α 1 ) 2 β 1 δγ stoichiometry, and are found at the neuromuscular junctions in vertebrates as well as in the Page 
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A c c e p t e d M a n u s c r i p t 5 electric organs of some fish such as Torpedo marmorata. On the other hand, neuronal nAChRs are composed of α (α 2 -α 10 ) and β (β 2 -β 4 ) subunits [10] . These subunits can assemble to form heteropentamers from combinations of α 2 , α 3 , α 4 , α 6 with either β 2 or β 4 , or with the addition of α 5 and/or β 3 subunits. Whereas the extent of the pentamer diversity is not yet fully described, it is generally accepted that neuronal nAChRs contain at least two α subunits. The α 7 -α 9 subunits can assemble as functional homopentameric receptors or as α subunit heteropentamers, and the α 10 subunit forms heteropentamers with the α 9 subunit [10] .
Neuronal nAChRs are predominantly found on presynaptic nerve terminals where they modulate the release of neurotransmitters. The different subtypes of neuronal nAChRs display a complex expression profile in the brain. Receptor subtype stoichiometry and distribution together with their role in distinct behavioral responses are under investigation.
Given the complexity in structure and function of nAChRs several challenges remain.
Specific targeting of a distinct nAChR subtype to treat neuronal disease is definitely an issue, which argues for in-depth structural investigation of the different ligand binding sites and how these data relate to receptor function.
Here, we aim at reviewing data from some of the detailed structural studies on AChBPs, which have contributed to shape our current understanding of ligand binding to nAChRs.
Tools towards nAChR structure
Many attempts have been made to gain structural data for integral membrane-bound nAChRs through the use of X-ray crystallography [11, 12] . However, these experiments have been unfruitful so far, probably underlining the difficulty faced in obtaining sufficient amounts of integral membrane proteins in a homogeneous state that makes crystallization possible.
Substantial progress however, was achieved through the cryo-electron microscopic analysis of Page 6 of 44 A c c e p t e d M a n u s c r i p t 6 the Torpedo marmorata muscle-type nAChR to a resolution of 4Å (PDB 2BG9) [13] [14] [15] .
Whereas highly informative regarding the general architecture of nAChRs, the relatively low resolution of the solved structure led to a less well-defined view of the protomer-protomer interface constituting the receptor ligand binding site.
An important breakthrough in the understanding of CLR structure, in particular with respect to the ligand binding mechanisms, came from the characterization and structural determination of molluscan acetylcholine binding protein (AChBP) [16, 17] . AChBP is secreted by molluscan glial cells and is homologous to the extracellular LBD of nAChRs, but lacking their transmembrane domain. AChBPs from Lymnaea stagnalis [17] , Bulinus truncatus [18] and Aplysia californica [19] share only a 20-24% sequence identity with nAChRs ( Figure 1a ) but display a striking structural resemblance with the Torpedo nAChR or mouse α1 nAChR protomer (Figure 1b) . Nicotinic ligand binding to these AChBPs was assayed through different methods such as radioligand ( 125 I-αBungarotoxin) displacement, surface plasmon resonance [20] [21] [22] , isothermal titration calorimetry [18] or intrinsic fluorescence quenching [19] , and all the AChBPs were found to display a pharmacological profile close to that of the homopentameric α 7 nAChR [18, 23] .
Taken together, AChBP provides a good alternative to characterize ligand binding in nAChRs. Hence, CLR modeling strategies have heavily relied on the X-ray structures of AChBPs and their complexes together with the structure of the Torpedo nAChR [24] [25] [26] [27] . The availability of the recently solved X-ray structure of the monomeric mouse α 1 nAChR subunit in complex with α-Bungarotoxin [28] indeed illustrates that AChBP constitutes a very good model for studying nAChRs, especially when considering the high degree of structural similarity between the α 1 and AChBP structures; mouse α 1 nAChR subunit superposes to carbamylcholine-bound LsAChBP with an r.m.s. deviation of 1.29Å (Figure 1c ) [29] . Owing
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A c c e p t e d M a n u s c r i p t 7 to this high degree of structural identity, AChBP is also currently being used as a tool to search for subtype-specific nicotinic receptor ligands through a combined approach involving in silico docking, assaying AChBP binding to potential ligands, and the structural characterization of AChBP-ligand complexes by X-ray crystallography [30] . Such structural studies have also contributed to better understand the factors, which lead to the selectivity of neonicotinoid insecticides such as thiacloprid or imidacloprid for invertebrate nAChRs [31, 32] .
Furthermore, the recently solved structures of the integral membrane proteins of the prokaryotic Erwinia chrysanthemi ELIC [33] and Gloeobacter violaceus GLIC [34, 35] , displaying an architecture very close to that of the Torpedo nAChR also now provide a novel avenue for studying gating mechanisms from a structural standpoint. A c c e p t e d M a n u s c r i p t 8 interactions in the stabilization of the nicotinic ligand cation [36, 37] . Structures of AChBP complexes with these small agonists indeed reveal that the tertiary nitrogen of nicotine and epibatidine or the quaternary nitrogen of carbamylcholine interact with the negative charge generated by the π electrons from the side chains of the residues making up the aromatic cage [23, 38] . Polar nitrogens can also contribute to ligand stabilization in the binding pocket through a hydrogen bond with the main chain carbonyl group of the conserved tryptophan from the B loop. The nicotine-bound X-ray structure of AChBP [23] clearly shows that the carbonyl group of LsAChBP W143 is involved in a hydrogen bond with the nitrogen from the nicotine pyrrolidine moiety. This carbonyl group is stabilized by a hydrogen bond between the NH group from the peptide bond between residues 143 and 144 and the negatively charged D85 side chain. The analysis of several nAChR mutants further indicates that the negative charge from the conserved nAChR α subunit D89 plays a key role in receptor activation, affecting this event in an acetylcholine concentration dependent manner [39] .
Canonical nAChR ligand binding site
Other studies making use of unnatural amino acids and featuring an nAChR with an ester bond between residues 143 and 144 (LsAChBP numbering) lead to substantially different conclusions [40, 41] . These studies suggest that a negative charge in position 89 of the nAChR α subunit is not essential in receptor function, but rather that D89 would be responsible in shaping the binding site of the receptor through an extensive hydrogen bond network, hence correctly positioning the conserved tryptophan residue. The loss of the planarity in the bond between residues 143 and 144 (LsAChBP numbering) through the substitution of the peptide bond by an ester [40, 41] , however introduces a further uncharacterized variable in the picture, and hence leaves this issue unresolved.
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A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t 10 triple mutant (kD >10000nM) displays an inverse trend [18] . This result clearly implies that other residues located outside the binding site are relevant for nAChR ligand binding.
Further evidence pointing to the influence on the binding affinity of nAChRs of residues located outside of the ligand binding site comes from recent work comparing the muscle-type or neuronal α 7 nAChRs to the neuronal α 4 β 2 nAChR [42] . Whereas these nAChRs contain the same conserved binding residues at their ligand binding protomer-protomer interface, it has been shown that a cation-π interaction was absent in the nicotine activation of the muscle-type nAChR, suggesting that this interaction discriminates between high affinity neuronal receptors and low affinity muscle-type receptors [43] . The higher nicotine binding affinity of the α 4 β 2 nAChR compared to the α 7 or muscle-type nAChRs was explained by mutagenesis studies. The authors suggest that the presence of a lysine at position 153, four residues away from the conserved binding site tryptophan in the α 4 β 2 nAChR, leads to the formation of a hydrogen bond between loops B and C, shaping the aromatic cage such that W149 is positioned to make close contact with nicotine [42] . Molecular dynamics simulations of the α 7 nAChR suggest that the G153, also present in the muscle-type nAChR, would hamper the formation of a hydrogen bond between loops B and C, hence explaining the comparatively lower nicotine binding affinities displayed by these two receptors [42] . Nature provides for various small molecules such as toxins originating from plants, which display nAChR subtype selectivity. One such compound is lobeline, a natural alkaloid found in Lobelia inflata, which has been used as emetic, for respiratory stimulation as well as a smoking cessation aid [44] . Lobeline displays a 100-fold higher binding affinity for Aplysia californica AChBP than for LsAChBP, and acts as a partial agonist for the α 3 β 2 and α 4 β 2 subtype neuronal nAChRs. The structural characterization of the AcAChBP-lobeline complex provides an interesting view on the structural plasticity of the ligand binding site of nAChRs [38] .
Characterizing the plasticity of the nAChR ligand binding site
The structure shows that the ligand is stabilized through π-π interactions between the central piperidine ring of lobeline and W145, which bring the ligand tertiary amine to hydrogen bonding distance with the carbonyl group of the conserved tryptophan residue. The ligand further interacts with complementary face residues from loop D in the apical region of the binding site (Figure 5a ). More interestingly, the basal part of the ligand delineates a novel sub-pocket in the ligand-binding site which results from the flipping of the Y91 side chain originating from loop F (Figure 5b ). This novel pocket is lined by three residues, i.e., K141, D195 and G143 (Figure 5c ), which are highly conserved in AChBPs and α-type nAChR protomers. The Y91 flip is stabilized by three polar interactions involving Q37, S167 and Y53
in AcAChBP.
AChBP-Methyllycaconitine complex
Methyllycaconitine (MLA) is another plant alkaloid originating from seeds of the Aconitum or Delphinium families. This compound is described as being highly selective for the α 7 nAChR [38] . The structure of AcAChBP in complex with MLA provides some indications on the selectivity determinants governing the binding of this ligand to nAChRs [38] . α 7 nAChR subtype specificity arises from the N-phenyl succinimide moiety of MLA, linked via a flexible ester bond to the lycoctonine moiety which provides the tertiary amine stabilized by the conserved binding site tryptophan residue. The MLA N-phenyl succinimide moiety nests itself in a pocket located at the basal region of AcAChBP, lined by residues S92, M122, K141, Q184, D195 from the principal face and Q36 and S165 from the complementary face ( Figure 6 ). The ester link carbonyl group is stabilized by Y53 from the complementary face loop D.
The AcAChBP-lobeline structure reveals that subtle side chain rearrangements as observed for Y91 can occur in the nAChR ligand binding site in order to accommodate a ligand. The
AcAChBP-MLA structure provides another good example of novel, previously unpredicted, weakly conserved binding pockets potentially contributing to the selectivity of nAChRs.
Investigating switches in nAChR selectivity between different ligands
Venoms from cone snails provide interesting libraries of peptide toxins displaying a high affinity for voltage-or ligand-gated ion channels and have been successfully used as structural probes to characterize nAChRs [9, 46, 47] . α-conotoxins, that specifically target nAChRs, display a consensus fold with a central helical region braced by two conserved disulphide bridges ( Figure 7 ). This organization confers a rigid framework to the peptide. This rigidity together with the diversity in amino acid composition displayed by α-conotoxins ensures their unique selectivity for different nAChR subtypes. These conotoxins have been classified into different families (α3/5, α4/3, α4/6 and α4/7) based on the number of residues between the second and third cysteine residues and between the third and fourth cysteines [46] .
Page 13 of 44
A c c e p t e d M a n u s c r i p t 13
AChBP-PnIA complex
PnIA is a member of the α4/7 α-conotoxin family, selective for the α 3 β 2 nAChR subtype, with a 25-fold higher binding affinity for the α 3 β 2 subtype than for the homopentameric α 7 receptor [9, 48, 49] . A point mutation in the toxin, resulting in PnIA(A10L) results in a complete switch in the selectivity of this toxin towards the α 7 nAChR [48, 49] . The PnIA(A10L D14K) variant displays a higher affinity towards LsAChBP and a 3-fold increased binding affinity for the chick α 7 nAChR, but does not display a significant difference in binding with the human [20] . Docking studies performed on the α 7 nAChR further indicate that a series of nAChR specific residues could also affect ligand binding selectivity and affinity [20] .
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AChBP-ImI complex
ImI is a member of the α4/3 α-conotoxin family, selective for the α 7 and α 3 β 2 nAChRs [50] .
This conotoxin further displays a 14.000-fold higher binding affinity for AcAChBP than for
LsAChBP [38] . IMI-AcAChBP co-crystal structures [22, 38] show that ImI is stabilized in the binding site in the same orientation as PnIA(A10L D14K) albeit through a broader range of interactions [20] . by an arginine present in LsAChBP is very likely to induce a steric clash with W10, hence the lower observed affinity of ImI for LsAChBP. High affinity ImI binding to the α 3 β 2 nAChR was found to rest on the presence of L119 in the nAChR [51] . This residue corresponds to I116 in AcAChBP but to a larger methionine in LsAChBP, and could also be responsible for the differences in affinity observed between the two AChBPs. Based on the available ImIAChBP complex structures, the higher affinity of ImI for the α 7 and α 3 β 2 nAChRs compared to the α 9 and α 3 β 4 nAChRs can be rationalized. Indeed, the substitution of both Q55 and T108
by arginines or lysines in α 9 and α 3 β 4 nAChRs would result in steric clashes with the ImI C3
and W10 respectively, hence contributing to lower observed affinities for these receptor subtypes [22] .
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AChBP-TxIA complex
TxIA is another α4/7 conotoxin isolated from the Conus textile snail. It was discovered when using AChBP as bait to fish out novel nAChR subtype selective conotoxins [21] . TxIA binds with high affinity to LsAChBP, followed by the α 3 β 2 and α 7 subtype receptors. This conotoxin presents only a 3-residue difference with the α4/7 type conotoxin PnIA, whereas displaying a 600-fold difference in binding affinity with LsAChBP. The PnIA(A10L) variant improves affinity over PnIA by a 12.5-fold factor for LsAChBP, a 20-fold factor for the α 7 nAChR, but decreases affinity for the α 3 β 2 nAChR by a 10-fold factor. Conversely, the TxIA(A10L) mutant did not show any affinity change for LsAChBP, but showed a 12-fold and 2-fold improvement in affinity towards the α 7 and α 3 β 2 nAChRs, respectively. From these data, it was concluded that a long chain hydrophobic residue in position 9 or 10 of the conotoxin (I9 in TxIA, L10 in PnIA(A10L)) was required for high affinity binding to LsAChBP as well as to the α 7 subtype nAChR, but not to the α 3 β 2 subtype. The substitution of the PnIA(A10L) L5
residue by the TxIA R5 improves LsAChBP binding by 220-fold and also improves α 3 β 2 subtype binding by 10-fold. The PnIA(A10L L5R) variant does not show any difference in affinity for the α 7 subtype nAChR. This dramatic increase in affinity of the PnIA(A10L L5R) variant for LsAChBP and the α 3 β 2 subtype highlights the importance of the R5 residue in the selective binding of the conotoxin to these two proteins ( Figure 10 ).
The co-crystal structure of the AcAChBP-TxIA(A10L) variant [21] shows that the toxin is bound in a different orientation in the binding site as compared to ImI [22, 38] or PnIA(A10L D14K) [20] . The 20° downward tilt of the toxin in the binding site is correlated with a projection of the TxIA(A10L) R5 residue deep into the binding site principal face. This R5 makes a hydrogen bond with loop C Y185 and a salt bridge with loop C D195. The mutation of D195 into alanine or asparagine shows no effect on nicotine or PnIA(A10L D14K) binding On the other hand, no effect was detected in the activity of R5 containing toxins against the D195A-α 7 . This could be explained by the fact that the TxIA(A10L) would adopt a PnIA(A10L D14K) like orientation in the α 7 binding site, which would hamper the toxin R5-α 7 D195 interaction.
Furthermore, docking studies show that the α 7 D195 is likely to form an internal salt bridge with K184, and would not be available for interaction with the TxIA(A10L) R5 residue.
Neonicotinoids contribute to characterize species selectivity in nAChRs
Neonicotinoid insecticides such as imidacloprid effectively target insect nAChRs and display low affinity for mammalian nAChRs. Co-crystal structures of imidacloprid with LsAChBP LsAChBP M114, which corresponds to basic or polar residues in the α 1 , α 2 or α 3 Drosophila melanogaster nAChRs and to non-polar residues in vertebrate nAChR subunits, is positioned close to the nitroimine group of the ligand. This chemical group is likely to accept hydrogen bonds from residues equivalent to the LsAChBP M114 in the insect α nAChR subtypes [31] .
The imidacloprid sensitivity of the chick α 7 nAChR is affected by mutation of the residue corresponding to the LsAChBP Q55 [52] . Mutating this chick α 7 nAChR glutamine to arginine results in an increased sensitivity of the receptor to imidacloprid whereas mutating this residue to a glutamate induces a lower affinity for the ligand. Concordantly, insect β nAChR subtypes display basic residues at the same position contrary to vertebrate β nAChRs subtypes. Only the human β 4 nAChR subunit contains a lysine (K75) at that position. The potential sensitization caused by this residue is relieved by a glutamate two residues downstream, which might interfere with the interaction between the lysine and the nitro group of imidacloprid [31] .
The analysis of the co-crystal structure of LsAChBP with imidacloprid also indicates that S186 in loop C makes hydrogen bonds with E163 and Y164 in loop F [31] . The mutation of the Drosophila α 2 subunit proline (P243) to glutamate, equivalent to LsAChBP E163, was further found to decrease the sensitivity of the α 2 β 2 nAChR to imidacloprid [53] . Conversely, mutating the human α 4 subunit glutamate equivalent to LsAChBP E163 to a proline leads to an increase in sensitivity of the α 4 β 2 nAChR to imidacloprid [53] . Taking these data into account, it has been suggested that in heteromeric vertebrate nAChRs, the presence of acidic residues in the position equivalent to LsAChBP S186 would lead to electrostatic repulsion of acidic residues in the loop F on the complementary face. Such acidic residues are not found in the C loop of α subunits of heteromeric insect nAChRs, hence the increased binding efficiency of insecticide neonicotinoids to these receptors [31] .
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However, the structural characterization of AcAChBP in complex with imidacloprid provides an alternate view on how loop C residues participate in neonicotinoid binding in nAChRs [32] . This structure shows that loop C displays a higher degree of inward positioning towards the ligand binding site compared to LsAChBP (Figure 11b ), in line with the higher imidacloprid sensitivity observed for AcAChBP (Ki = 19 nM) compared to LsAChBP (Ki = 970nM) [54] . Furthermore in this structure AcAChBP S186 is not involved in hydrogen bonding with residues originating from the complementary face loop F but is involved in direct hydrogen bonding with the nitro group of imidacloprid (Figure 11b ).
Connecting ligand binding to Cys-loop motion in nAChRs
Ligand binding to nAChRs can correlate with small side chain movements resulting in the binding site plasticity and this event is invariably accompanied by the motion of the C loop. 
Prokaryotic ligand gated ion channels: new perspectives into cys-loop receptor research
Until recently it was thought that ligand gated ion channels (LGICs) were only expressed by multi-cellular eukaryotic organisms. However the availability of a large number of genomes has led to the discovery of novel ligand gated ion channels from bacterial sources [56] . This discovery has spurred much enthusiasm in the CLR field, and rapidly resulted in the electrophysiological characterization of the Gloeobacter violaceus GLIC, one of the members of this new protein family, showing that the channel was activated by protons [57] . These results were quickly followed by the structural characterization of full length Erwinia chrysanthemi ELIC, an orthologue of GLIC, in a closed state [33] , and by those of full length
GLIC in an open state [34, 35] . These structural data indicate that the nAChR architecture is mostly conserved in both ELIC and GLIC (Figure 13a ).
Despite displaying a low level of sequence conservation, the comparison of the structures of ELIC and GLIC provides insight into the gating mechanism in CLRs [58] . The open state in GLIC correlates with a concerted twist motion compared to ELIC in its closed state. GLIC hence displays an anti-clockwise rotation of its ECD, accompanied by a clockwise rotation of its transmembrane region relative to the ELIC structure. In the ECD, a rotation of 8° is also observed for the core of the β-sandwich around an axis perpendicular to the inner sheet of the β-sandwich [34] .
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Such global conformational changes are absent in AChBP. Therefore, it has been suggested that this protein is stabilized in a fixed conformation and most likely resembles a nAChR in its desensitized state [59] .
Despite the fact that a ligand as small as a proton could potentially activate ELIC [33] , this protein displays an intriguing protomer-protomer interface containing aromatic residues which are reminiscent of the aromatic cage observed in the AChBP ligand binding site illustrates how an alanine to leucine mutation in position 10 of the conotoxin brings about a complete switch in its selectivity profile from α 3 β 2 to the α 7 . A close-up view on conotoxin L10 residue shows that it is nested in a pocket lined by poorly conserved residues, which might lead to α 7 nAChR selectivity. 
